(Q43640821)

25 November 2017

Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy (English)

1 reference

25 November 2017

0 references

1 reference

Francesca Pozza

1

1 reference

25 November 2017

Cinzia Piovesan

2

1 reference

25 November 2017

Francesca Russo

3

1 reference

25 November 2017

Antonino Bella

4

1 reference

25 November 2017

Patrizio Pezzotti

5

1 reference

25 November 2017

Leonardo Emberti Gialloreti

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

19 October 2011

1 reference

25 November 2017

1 reference

25 November 2017

29

1 reference

25 November 2017

51

1 reference

25 November 2017

9480-9487

1 reference

Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

THE EPIDEMIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Varicella vaccination in Europe: are we ready for a universal childhood programme?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Varicella vaccine effectiveness in the US vaccination program: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

[Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Varicella: epidemiological aspects and vaccination coverage in the Veneto Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Assessment of varicella underreporting in Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Testing and dating of structural changes in practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

strucchange: An R Package for Testing for Structural Change in Linear Regression Models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Varicella vaccination in Europe - taking the practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Epidemiology of varicella hospitalizations in the United States, 1995-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

The effect of active immunization on varicella-related hospitalizations in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Impact of varicella vaccination on health care utilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Modelling the impact of varicella vaccination on varicella and zoster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Humoral and cellular immunity to varicella-zoster virus: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

The seroepidemiology of varicella in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

[Impact of routine pediatric varicella vaccination on the epidemiology of herpes zoster]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.022

10.1016/J.VACCINE.2011.10.022

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference